V020-3191 Screening compound: N-({2-[(2-fluorophenyl)methanesulfonyl]-1-[(oxolan-2-yl)methyl]-1H-imidazol-5-yl}methyl)-N-(2-methoxyethyl)-2-phenylacetamide

V020-3191 Screening compound: N-({2-[(2-fluorophenyl)methanesulfonyl]-1-[(oxolan-2-yl)methyl]-1H-imidazol-5-yl}methyl)-N-(2-methoxyethyl)-2-phenylacetamide
V020-3191 Screening compound: N-({2-[(2-fluorophenyl)methanesulfonyl]-1-[(oxolan-2-yl)methyl]-1H-imidazol-5-yl}methyl)-N-(2-methoxyethyl)-2-phenylacetamide alternative view

Chemical Structure Depiction of ChemDiv screening compound V020-3191
N-({2-[(2-fluorophenyl)methanesulfonyl]-1-[(oxolan-2-yl)methyl]-1H-imidazol-5-yl}methyl)-N-(2-methoxyethyl)-2-phenylacetamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

V020-3191

Molecular Formula

C27H32FN3O5S (C27 H32 FN3 O5 S)

Compound Name

N-({2-[(2-fluorophenyl)methanesulfonyl]-1-[(oxolan-2-yl)methyl]-1H-imidazol-5-yl}methyl)-N-(2-methoxyethyl)-2-phenylacetamide

IUPAC name

N-({2-[(2-fluorophenyl)methanesulfonyl]-1-[(oxolan-2-yl)methyl]-1H-imidazol-5-yl}methyl)-N-(2-methoxyethyl)-2-phenylacetamide

SMILES

COCCN(Cc(n1CC2OCCC2)cnc1S(Cc(cccc1)c1F)(=O)=O)C(Cc1ccccc1)=O

InChI

InChI=1S/C27H32FN3O5S/c1-35-15-13-30(26(32)16-21-8-3-2-4-9-21)18-23-17-29-27(31(23)19-24-11-7-14-36-24)37(33,34)20-22-10-5-6-12-25(22)28/h2-6,8-10,12,17,24H,7,11,13-16,18-20H2,1H3/t24-/m1/s1

InChI Key

WTIKAEHZEFWBSM-XMMPIXPASA-N

MDL Number (MFCD)

MFCD19815786

Chemical and Physical Properties

Saltdata

not_available

Molecular Weight

529.63

Hydrogen Bond Acceptors Count

9.00

Hydrogen Bond Donors Count

0.00

Rotatable Bond Count

13.00

Number of Nitrogen and Oxygen Atoms

8

Partition Coefficient, logP

3.121

Distribution Coefficient, logD

3.121

Water Solubility, LogSw

-3.07

Polar Surface Area

73.310

Acid Dissociation Constant (pKa)

17.63

Base Dissociation Constant (pKb)

-2.74

Number of Chiral Centers

1.00

Percent sp3 carbon bonding

40.70

V020-3191 in Drug Discovery

Included in Screening Libraries

3D-Pharmacophore Based Diversity Library (49813 compounds)

Protein Arginine Methyltransferases Library (27925 compounds)

?ysteine Targeted Covalent Library (39471 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Musculoskeletal
  • Digestive system
  • Respiratory tract
  • Male
  • Female
  • Hemic and lymphatic
  • Metabolic
Targets:
  • Others
Mechanism of action:
  • Epigenetic

References: we are preparing a list of scientific research reports with V020-3191 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound V020-3191?
Check Price and Availability of V020-3191, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of V020-3191 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for V020-3191
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for V020-3191
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of V020-3191 available by request